Trends in blood transfusion, hydroxyurea use, and iron overload among children with sickle cell disease enrolled in Medicaid, 2004–2019
A study that conducted a serial cross-sectional cohort study of pediatric SCD patients from 2004 to 2019 using Georgia Medicaid claims data. We evaluated iron overload diagnosis, monitoring, and chelation use. Among children with sickle cell anemia (SCA), we examined rates of transfusions and hydroxyurea use. The Cochran–Armitage test was used to assess trend.
Proposed citation: Tang, A., Zhou, M., Maillis, A., Lai, K., Lane, P., Snyder, A. (2022). Trends in blood transfusion, hydroxyurea use, and iron overload among children with sickle cell disease enrolled in Medicaid, 2004-2009. Pediatric Blood & Cancer. DOI: 10.1002/pbc.30152.
File | Action |
---|---|
Trends in blood transfusion, hydroxyurea use, and iron overload among children with sickle cell disease enrolled in Medicaid, 2004–2019 | Download |
- 0.00 KB File Size
- January 3, 2023 Create Date
- June 15, 2023 Last Updated